Skip to content

A medical records based retrospective study for the effect of adverse childhood experiences on treatments efficacy in major depressive disorder

Effect of adverse childhood experiences on treatments efficacy in patients with major depressive disorder

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100044948
Enrollment
Unknown
Registered
2021-04-02
Start date
2021-04-01
Completion date
Unknown
Last updated
2021-11-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major Depressive Disorder

Interventions

fluoxetine group:Nil
sertraline group:Nil
venlafaxine-extended release group:Nil
duloxetine hydrochloride group:Nil

Sponsors

The Second Affiliated Hospital of Kunming Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Depressive episode patients who meet the DSM-IV diagnostic criteria.

Exclusion criteria

Exclusion criteria: 1.Patients suffering from mental retardation, or developmental diseases, or major physical diseases; 2.Co-morbidities include obsessive-compulsive disorder, post-traumatic stress disorder, alcohol use disorder, and psychosis; 3.Suffer from thyroid disease, endocrine disease; 4.Women in pregnancy, lactation, menopause, etc..

Design outcomes

Primary

MeasureTime frame
clinical symptoms;Stress level;

Countries

China

Contacts

Public ContactYang Jianzhong

The Second Affiliated Hospital of Kunming Medical University

jzhyang2004@163.com+86 13577097094

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026